Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | XP Inc. XP | BlackRock Inc. BLK | 34,482,479 8.300% | 5,623,542 (+19.49%) | Filing History |
| 2026-01-21 12:30 pm Sale | 2025-12-31 | 13G | Grupo Televisa, S.A.B. TV | BlackRock Inc. BLK | 134,408,681 5.300% | -139,724,260 (-50.97%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Telefonaktiebolaget LM Ericsson (publ) ERIC | BlackRock Inc. BLK | 159,358,047 5.100% | 14,227,981 (+9.80%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | ACRES Commercial Realty Corp. ACR | BlackRock Inc. BLK | 466,499 6.400% | 85,790 (+22.53%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | BlackRock Inc. BLK | 11,992,448 7.900% | 2,051,602 (+20.64%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Affirm Holdings, Inc. AFRM | BlackRock Inc. BLK | 14,766,952 5.100% | 14,766,952 (New Position) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Ares Management Corporation ARES | BlackRock Inc. BLK | 15,778,507 7.200% | 4,622,400 (+41.43%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP | BlackRock Inc. BLK | 2,319,341 5.600% | 312,003 (+15.54%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Arrowhead Pharmaceuticals, Inc. ARWR | BlackRock Inc. BLK | 20,323,221 15.000% | 1,310,366 (+6.89%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Astera Labs, Inc. Common Stock ALAB | BlackRock Inc. BLK | 10,507,515 6.200% | 2,154,842 (+25.80%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Bankwell Financial Group, Inc. BWFG | BlackRock Inc. BLK | 409,432 5.200% | 16,872 (+4.30%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Bentley Systems, Incorporated BSY | BlackRock Inc. BLK | 19,138,817 6.600% | 5,277,070 (+38.07%) | Filing History |
| 2026-01-21 12:30 pm Sale | 2025-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN | BlackRock Inc. BLK | 17,560,751 9.100% | -3,059,428 (-14.84%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | CB Financial Services, Inc. CBFV | BlackRock Inc. BLK | 254,204 5.100% | 254,204 (New Position) | Filing History |
| 2026-01-21 12:30 pm Sale | 2025-12-31 | 13G | Cass Information Systems, Inc. CASS | BlackRock Inc. BLK | 895,886 6.800% | -185,555 (-17.16%) | Filing History |
| 2026-01-21 12:30 pm Sale | 2025-12-31 | 13G | Clearwater Paper Corporation CLW | BlackRock Inc. BLK | 1,373,009 8.600% | -288,537 (-17.37%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Cogent Biosciences, Inc. COGT | BlackRock Inc. BLK | 11,370,224 6.500% | 4,614,640 (+68.31%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Compass Therapeutics, Inc. CMPX | BlackRock Inc. BLK | 9,271,644 5.200% | 2,872,656 (+44.89%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BlackRock Inc. BLK | 3,625,824 4.600% | 372,914 (+11.46%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | Gossamer Bio, Inc. GOSS | BlackRock Inc. BLK | 15,065,708 6.500% | 2,930,369 (+24.15%) | Filing History |